Healio (2/7) reports, “Ketamine provided rapid benefits to hospitalized patients with suicidal ideation; however, more research is needed to determine its long-term impact,” investigators concluded in a 156-patient, “six-week prospective, double-blind, superiority, randomized, placebo-controlled trial.” The findings were published online Feb. 2 in The BMJ.  (SOURCE: APA Headlines)